EU Approves Takeda’s Injectable Entyvio for IBD

EU OK Follows FDA’s Recent Rejection Of The New Formulation

Takeda has won EU approval for an injectable version of Entyvio to treat ulcerative colitis or Crohn’s disease, in contrast to the FDA’s rejection in December.

Digestive_System
Injectable Entyvio EU approval is for ulcerative colitis and Crohn’s disease • Source: Shutterstock

More from New Products

More from Scrip